A patient who takes a phosphodiesterase (PDE) inhibitor may develop nonarteritic ischemic optic neuropathy (NAION). It is uncertain if the PDE inhibitor is the cause of the NAION or just being taken coincidentally in a patient with poor ocular perfusion. Fortunately this is a rare condition.